Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5899
    -0.0007 (-0.11%)
     
  • NZD/EUR

    0.5527
    -0.0018 (-0.32%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.28
    +0.55 (+0.66%)
     
  • GOLD

    2,409.30
    +11.30 (+0.47%)
     
  • NASDAQ

    17,185.49
    -208.83 (-1.20%)
     
  • FTSE

    7,896.78
    +19.73 (+0.25%)
     
  • Dow Jones

    37,925.67
    +150.29 (+0.40%)
     
  • DAX

    17,754.03
    -83.37 (-0.47%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.0960
    -0.1580 (-0.17%)
     

What to Expect from Clorox’s Fiscal 2Q18 Sales

What to Expect from Clorox’s Fiscal 2Q18 Sales

The company’s top line is expected to benefit from higher volumes, driven by innovation-led new products and supported by efficient marketing. In addition, strength across all segments and higher pricing in the international markets should further support the company’s sales growth rate. Clorox has a strong portfolio of category-leading brands that have helped the company to report industry-leading sales and volumes growth amid a challenging operating environment.